SCHEMBL1684036

SCHEMBL1684036

CCC(C)CC(C)CC(C)CC(C)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 3/20 0.43
FOLH1 Q04609 2/20 0.43
ENPEP Q07075 2/20 0.43
ACE2 Q9BYF1 1/20 0.41
GABRR1 P24046 2/20 0.39
CYP1A2 P05177 1/20 0.39
BLM P54132 1/20 0.39
SLC1A3 P43003 1/20 0.35
SLC1A2 P43004 1/20 0.35
SLC1A1 P43005 1/20 0.35
RNPEP Q9H4A4 1/20 0.34
SLC7A5 Q01650 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5738809 1.00 NAALAD2 (0.43) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL5879035 1.00 NAALAD2 (0.43) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL9550634 0.95 NAALAD2 (0.46) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL1572858 0.95 NAALAD2 (0.46) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL9272361 0.95 NAALAD2 (0.46) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL23499629 0.90 NAALAD2 (0.50) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL23499736 0.87 NAALAD2 (0.52) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL29184102 0.85 BLM (0.53) NAALAD2FOLH1ENPEPACE2GABRR1
SCHEMBL7142825 0.83 SLC1A3 (0.37) ENPEPACE2SLC1A3SLC1A2SLC1A1
SCHEMBL17618960 0.82 SLC1A3 (0.52) NAALAD2FOLH1ENPEPACE2GABRR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006024502-A2 METHOD FOR PRODUCING POLYMETHYL-BRANCHED OMEGA-1, OMEGA-2 OR OMEGA-3 ALCOHOLS OR KETONES, USING THE BACILLUS MEGATERIUM HYDROXYLASE SYSTEM GESELLSCHAFT FUER BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) (DE) 2006-03-09 WO claimed
WO-2024039733-A1 METHODS OF CONTROLLING LIPID NANOCRYSTAL PARTICLE SIZE AND LIPID NANOCRYSTALS PRODUCED BY SUCH METHODS MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. (US) 2024-02-22 WO disclosed
WO-2024039729-A1 ANTIFUNGAL AGENT ENCAPSULATED IN A LIPID NANOCRYSTAL FOR TREATING MUCORMYCOSIS MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. (US) 2024-02-22 WO disclosed
EP-2704688-B1 COCHLEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME MATINAS BIOPHARMA NANOTECHNOLOGIES INC (US) 2019-07-10 EP disclosed
EP-1624858-B1 NOVEL ENCOCHLEATION METHODS UNIV RUTGERS (US) 2018-06-06 EP disclosed
US-9974745-B2 Encochleation methods, cochleates and methods of use RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2018-05-22 US disclosed
US-9259392-B2 Cochleate compositions directed against expression of proteins RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2016-02-16 US disclosed
US-20140242153-A1 NOVEL ENCOCHLEATION METHODS, COCHLEATES AND METHODS OF USE RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-08-28 US disclosed
US-20140220108-A1 COCHLEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) 2014-08-07 US disclosed
US-20140186430-A1 COCHLEATE COMPOSITIONS DIRECTED AGAINST EXPRESSION OF PROTEINS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-07-03 US disclosed
WO-2004091578-A2 NOVEL ENCOCHLEATION METHODS, COCHLEATES AND METHODS OF USE BIODELIVERY SCIENCES INTERNATIONAL, INC. (US) 2004-10-28 WO disclosed
WO-2004091572-A2 COCHLEATE COMPOSITIONS DIRECTED AGAINST EXPRESSION OF PROTEINS BIODELIVERY SCIENCES INTERNATIONAL, INC. (US) 2004-10-28 WO disclosed
WO-2004064805-A1 COCHLEATE PREPARATIONS OF FRAGILE NUTRIENTS BIODELIVERY SCIENCES INTERNATIONAL, INC. (US) 2004-08-05 WO disclosed
US-20020120958-A1 Branched fatty acid lubricating compositions DUHOT PIERRE (FR) 2002-08-29 US disclosed
US-20020120957-A1 Method for producing branched fatty acids using genetically modified plants GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2002-08-29 US disclosed
US-6194383-B1 HOMOLOGOUS CYCLIC AMINO-ACID SEQUENCES HAVING DIFFERENT FATTY ACID RESIDUES SYNTHESIZED BY ACTINOPLANES SP.; PEPTIDE ANTIBIOTICS, LIPOPEPTIDES A 1437, A-M, EFFECTIVE AGAINST GRAMPOSITIVE BACTERIA AND GLYCOPEPTIDE-RESISTANT STRAINS HOECHST AKTIENGESELLSCHAFT (DE) 2001-02-27 US disclosed
EP-0864584-B1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use HOECHST AG (DE) 2000-12-20 EP disclosed
EP-0629636-B1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use HOECHST AG (DE) 1998-12-16 EP disclosed
EP-0864584-A1 Lipopetide from Actinoplanes sp. with pharmacological properties, process for its preparation and its use HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-16 EP disclosed
EP-0629636-A1 Lipopeptides from actinoplanes sp. endowed with pharmacological activity, process for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1994-12-21 EP disclosed